ZEGALOGUE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zegalogue (autoinjector), and what generic alternatives are available?
Zegalogue (autoinjector) is a drug marketed by Zealand Pharma and is included in one NDA. There are two patents protecting this drug.
This drug has thirty-three patent family members in twenty-four countries.
The generic ingredient in ZEGALOGUE (AUTOINJECTOR) is dasiglucagon hydrochloride. Two suppliers are listed for this compound. Additional details are available on the dasiglucagon hydrochloride profile page.
DrugPatentWatch® Generic Entry Outlook for Zegalogue (autoinjector)
Zegalogue (autoinjector) will be eligible for patent challenges on March 22, 2025. This date may extended up to six months if a pediatric exclusivity extension is applied to the drug's patents.
Indicators of Generic Entry
Summary for ZEGALOGUE (AUTOINJECTOR)
International Patents: | 33 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
DailyMed Link: | ZEGALOGUE (AUTOINJECTOR) at DailyMed |
Pharmacology for ZEGALOGUE (AUTOINJECTOR)
Drug Class | Antihypoglycemic Agent |
Mechanism of Action | Glucagon Receptor Agonists |
Physiological Effect | Increased Glycogenolysis |
Anatomical Therapeutic Chemical (ATC) Classes for ZEGALOGUE (AUTOINJECTOR)
US Patents and Regulatory Information for ZEGALOGUE (AUTOINJECTOR)
ZEGALOGUE (AUTOINJECTOR) is protected by two US patents and one FDA Regulatory Exclusivity.
Patents protecting ZEGALOGUE (AUTOINJECTOR)
Glucagon analogues
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: METHOD OF TREATING DIABETIC HYPOGLYCEMIA
FDA Regulatory Exclusivity protecting ZEGALOGUE (AUTOINJECTOR)
NEW CHEMICAL ENTITY
Exclusivity Expiration: ⤷ Try a Trial
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zealand Pharma | ZEGALOGUE (AUTOINJECTOR) | dasiglucagon hydrochloride | SOLUTION;SUBCUTANEOUS | 214231-002 | Mar 22, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Zealand Pharma | ZEGALOGUE (AUTOINJECTOR) | dasiglucagon hydrochloride | SOLUTION;SUBCUTANEOUS | 214231-002 | Mar 22, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Zealand Pharma | ZEGALOGUE (AUTOINJECTOR) | dasiglucagon hydrochloride | SOLUTION;SUBCUTANEOUS | 214231-002 | Mar 22, 2021 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ZEGALOGUE (AUTOINJECTOR)
See the table below for patents covering ZEGALOGUE (AUTOINJECTOR) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2014016300 | ⤷ Try a Trial | |
Denmark | 2875043 | ⤷ Try a Trial | |
Malaysia | 170671 | GLUCAGON ANALOGUES | ⤷ Try a Trial |
Mexico | 2015000990 | ANALOGOS DEL GLUCAGON. (GLUCAGON ANALOGUES.) | ⤷ Try a Trial |
China | 104662038 | Glucagon analogues | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |